Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis

NCT05406466 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Tislelizumab
DRUG: Lenvatinib
DRUG: Cryoablation

Sponsor

Fudan University